Loading...
Loading...
VAPO| Name | Value |
|---|---|
| Revenues | 18.7M |
| Cost of Revenue | 13.5M |
| Gross Profit | 5.1M |
| Operating Expense | 21.1M |
| Operating I/L | -16.0M |
| Other Income/Expense | -5.5M |
| Interest Income | 0.0M |
| Pretax | -21.5M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -21.4M |
Vapotherm, Inc. develops and sells proprietary high velocity therapy products for treating respiratory distress. Its precision flow systems, including Precision Flow Hi-VNI, deliver heated, humidified, and oxygenated air at high velocity through a nasal interface. The company also offers companion products such as Vapotherm Transfer Unit, Q50 compressor, and disposable patient circuits. Vapotherm's products are primarily sold to hospitals, providing a revenue stream through the sale of these medical devices and related accessories.
